|
Volumn 356, Issue 18, 2007, Pages 1801-1805
|
China and HIV - A window of opportunity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
DIDANOSINE;
EFAVIRENZ;
LAMIVUDINE;
METHADONE;
NEVIRAPINE;
STAVUDINE;
ZIDOVUDINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
BUDGET;
CHINA;
CORRELATION ANALYSIS;
DISEASE TRANSMISSION;
DRUG DEPENDENCE;
DRUG DETOXIFICATION;
EPIDEMIC;
GOVERNMENT;
HEALTH CARE COST;
HEALTH CARE ORGANIZATION;
HEALTH CARE POLICY;
HEALTH PROGRAM;
HIGH RISK BEHAVIOR;
HIGH RISK POPULATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE;
INFECTION CONTROL;
INFECTION PREVENTION;
LABORATORY TEST;
PATIENT COMPLIANCE;
PATIENT COUNSELING;
PATIENT IDENTIFICATION;
PRIORITY JOURNAL;
PROSTITUTION;
REVIEW;
RURAL AREA;
SEVERE ACUTE RESPIRATORY SYNDROME;
SOCIOECONOMICS;
STIGMA;
UNSPECIFIED SIDE EFFECT;
VIRUS LOAD;
ARTICLE;
FEMALE;
GOVERNMENT REGULATION;
INTERNATIONAL COOPERATION;
LEGAL ASPECT;
MALE;
PUBLIC HEALTH SERVICE;
SOCIAL PSYCHOLOGY;
SUBSTANCE ABUSE;
ANTI-HIV AGENTS;
CHINA;
DISEASE OUTBREAKS;
FEMALE;
GOVERNMENT REGULATION;
HEALTH POLICY;
HIV INFECTIONS;
HUMANS;
INTERNATIONAL COOPERATION;
MALE;
PREJUDICE;
PUBLIC HEALTH ADMINISTRATION;
SUBSTANCE ABUSE, INTRAVENOUS;
|
EID: 34247869041
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp078010 Document Type: Article |
Times cited : (50)
|
References (5)
|